BlackRock Fund Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

BlackRock Fund Advisors’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3K	Buy	2,655 +540	+26%	+$997	﹤0.01%	4137
2016 Q3	$5K	Buy	2,115 +201	+11%	+$437	﹤0.01%	4085
2016 Q2	$4K	Buy	1,914 +128	+7%	+$309	﹤0.01%	4146
2016 Q1	$3K	Buy	1,786 +308	+21%	+$661	﹤0.01%	4211
2015 Q4	$4K	Buy	+1,478	New	+$6.06K	﹤0.01%	4200
2015 Q2	–	Sell	-17,594	Closed	-$293K	–	3929
2015 Q1	$293K	Sell	17,594 -1,193	-6%	-$23.5K	﹤0.01%	3382
2014 Q4	$305K	Buy	18,787 +1,342	+8%	+$29.5K	﹤0.01%	3363
2014 Q3	$449K	Sell	17,445 -1,268	-7%	-$30.6K	﹤0.01%	3246
2014 Q2	$466K	Buy	18,713 +535	+3%	+$13.7K	﹤0.01%	3211
2014 Q1	$547K	Buy	18,178 +5,750	+46%	+$193K	﹤0.01%	3241
2013 Q4	$391K	Buy	12,428 +2,861	+30%	+$89.5K	﹤0.01%	3261
2013 Q3	$263K	Buy	9,567 +752	+9%	+$18.2K	﹤0.01%	3309
2013 Q2	$188K	Buy	+8,815	New	+$217K	﹤0.01%	3344

Other funds holding WINT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

BlackRock Fund Advisors's WINT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Windtree Therapeutics Inc (WINT) stake by 26% in Q4 2016, buying an estimated $997 and bringing the position to 2,655 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4137.

BlackRock Fund Advisors first reported a position in WINT in Q2 2013 and has held it in 13 quarters since. The position peaked at $547K in Q1 2014. 31 funds tracked by Wall St. Rank hold WINT as of Q4 2016.

BlackRock Fund Advisors held 2,655 shares of Windtree Therapeutics Inc worth $3K as of Q4 2016.
BlackRock Fund Advisors bought 540 Windtree Therapeutics Inc shares in Q4 2016, an estimated $997.
Windtree Therapeutics Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4137 holding.
BlackRock Fund Advisors first reported a position in Windtree Therapeutics Inc in Q2 2013 and has held it in 13 quarters since.
BlackRock Fund Advisors's Windtree Therapeutics Inc position peaked at $547K in Q1 2014.
31 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.